Taşkın, Ö. Et Al. 2006. Endometrial receptivity following use of 2 5 and 5 mg Day 3 7 letrozole in CC Resistant patients with PCOS.. ASRM 2006 , (New Orleans, United States Of America).

Taşkın, Ö., ERMAN, M., ÖZEKİNCİ, M., DEMİR, R., & sadık, s., (2006). Endometrial receptivity following use of 2 5 and 5 mg Day 3 7 letrozole in CC Resistant patients with PCOS. . ASRM 2006, New Orleans, United States Of America

Taşkın, ÖMÜR Et Al. "Endometrial receptivity following use of 2 5 and 5 mg Day 3 7 letrozole in CC Resistant patients with PCOS.," ASRM 2006, New Orleans, United States Of America, 2006

Taşkın, ÖMÜR Et Al. "Endometrial receptivity following use of 2 5 and 5 mg Day 3 7 letrozole in CC Resistant patients with PCOS.." ASRM 2006 , New Orleans, United States Of America, 2006

Taşkın, Ö. Et Al. (2006) . "Endometrial receptivity following use of 2 5 and 5 mg Day 3 7 letrozole in CC Resistant patients with PCOS.." ASRM 2006 , New Orleans, United States Of America.

@conferencepaper{conferencepaper, author={ÖMÜR TAŞKIN Et Al. }, title={Endometrial receptivity following use of 2 5 and 5 mg Day 3 7 letrozole in CC Resistant patients with PCOS.}, congress name={ASRM 2006}, city={New Orleans}, country={United States Of America}, year={2006}}